// App-Quantinova.ai

: The impact of MRE11 in nuclear to cytoplasmic ratio on outcomes in muscle invasive bladder cancer an analysis of NRG/RTOG 8802, 8903, 9506, 9706, 9906, and 0233.

Researchers

Presenter

  • Anthony Martin Magliocco

Principal Investigators

  • Jeff Simko

  • Jason A. Efstathiou

  • Phillip J Gray

  • Michael P Hagan

  • Donald S Kaufman

  • William J. Tester

  • Anthony L. Zietman

  • Susan M McCarthy

  • Alan C Hartford

  • Ashish Bharat Patel

  • Seth A. Rosenthal

  • David G McGowan

  • Richard H Greenberg

  • Michael A Schwartz

  • Mark E Augspurger

  • John A. Keech

  • Kathryn A Winter

  • William U. Shipley

Medical Centers

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

  • NRG Oncology Statistics and Data Management Center, Philadelphia, PA

  • University of California, San Francisco, San Francisco, CA

  • Massachusetts General Hosp Harvard Medcl School, Boston, MA

  • Massachusetts General Hospital, Boston, MA

  • Hunter Holmes McGuire Veterns Administration Medical Center, Richmond, VA

  • Massachusetts General Hospital, Boston, Massachusetts

  • Albert Einstein Cancer Ctr, Philadelphia, PA

  • Dartmouth Hitchcock Medical Center, Lebanon, NH

  • MD Anderson Cancer Center at Cooper, Camden, NJ

  • Sutter Cancer Center, Sacramento, CA

  • Cross Cancer Institute, Edmonton, AB, Canada

  • Virtua Voorhees, Voorhees, NJ

  • Mount Sinai Medical Center, Miami Beach, FL

  • Baptist MD Anderson Cancer Center, Jacksonville, FL

  • MultiCare Gig Harbor Medical Park, Gig Harbor, WA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved